Nutrition Business Journal
Is toxicity the flipside of enhanced bioavailability?

Is toxicity the flipside of enhanced bioavailability?

With the rise of nanotechnology, could increased bioavailability pose risks of toxicity?

A promising phytochemical is one thing. Proven effi cacy in the human body is an entirely different matter. “Some of the more popular botanicals have poor bioavailabi

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.